282. Congenital dyserythropoietic anemia Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target genes : 2 - Drug target pathways : 4
Congenital dyserythropoietic anemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 282 | Congenital dyserythropoietic anemia | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 2.000 |
| 6 | Parkinson disease | 2.000 |
| 21 | Mitochondrial disease | 2.000 |
| 299 | Cystic fibrosis | 2.000 |
| 2 | Amyotrophic lateral sclerosis | 2.000 |
| 63 | Idiopathic thrombocytopenic purpura | 2.000 |
| 46 | Malignant rheumatoid arthritis | 2.000 |
| 51 | Scleroderma | 2.000 |
| 65 | Primary immunodeficiency | 2.000 |
| 85 | Idiopathic interstitial pneumonia | 2.000 |
| 86 | Pulmonary arterial hypertension | 2.000 |
| 96 | Crohn disease | 2.000 |
| 98 | Eosinophilic gastrointestinal disease | 2.000 |
| 222 | Primary nephrotic syndrome | 2.000 |
| 271 | Ankylosing spondylitis | 2.000 |
| 8 | Huntington disease | 2.000 |
| 113 | Muscular dystrophy | 2.000 |
| 107 | Juvenile idiopathic arthritis | 2.000 |
| 298 | Hereditary pancreatitis | 2.000 |
| 97 | Ulcerative colitis | 2.000 |
| 225 | Congenital nephrogenic diabetes insipidus | 2.000 |
| 166 | Pseudoxanthoma elasticum | 2.000 |
| 294 | Congenital diaphragmatic hernia | 2.000 |
| 71 | Idiopathic osteonecrosis of the femoral head | 2.000 |